Navigation Links
Quigley Corporation Announces Final Results of Quigley Pharma's Phase IIb Study
Date:7/22/2009

12 weeks.

Number of patients (planned and analyzed):

The planned sample size of evaluable patients was 70 per arm (140 in total). Two hundred nineteen patients were randomized and enrolled; 109 and 110 patients were randomized to placebo and QR-333 treatment group, respectively.

Diagnosis and main criteria for inclusion:

Patients between the ages of 18 and 70 with a diagnosis of diabetic neuropathy were enrolled in the study.

Duration of treatment:

Treatment commenced at randomization (Visit 2) and continued for 12 weeks; study duration for each patient was approximately 22 weeks.

Endpoints:

Efficacy:

The primary efficacy objective is to demonstrate that treatment with QR-333 improves pain relief, as demonstrated through the VAS pain scale.

The secondary efficacy objective is to demonstrate that treatment with QR-333 improves symptomatic diabetic neuropathy, as demonstrated through the Symptom Assessment Score, Quality of Life questionnaires, and sleep questionnaires.

Safety:

Safety variables included adverse events (AEs), findings from physical and examinations, vital signs, laboratory safety data, 12-lead electrocardiograms (ECGs), and nerve conduction velocity (NCV) assessments.

About The Quigley Corporation

The Quigley Corporation (NASDAQ: QGLY, http://www.Quigleyco.com) is a diversified natural health medical science company. Its Cold Remedy segment is a leading marketer and manufacturer of the COLD-EEZE(R
'/>"/>

SOURCE Quigley Corporation
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine news :

1. Ted Karkus Named CEO of The Quigley Corporation; Robert V. Cuddihy, Jr. Named Chief Operating Officer
2. Dr. Richard Rosenbloom Resumes Services To The Quigley Corporations Pharma Subsidiary
3. Ted Karkus Appointed Interim Chief Executive Officer Of The Quigley Corporation
4. Ted Karkus and Karkus Slate of Directors Prevail in Federal Court, Seated as Directors of The Quigley Corporation; Ted Karkus Elected Chairman of the Board
5. The Quigley Corporation Announces Final Voting Results for 2009 Annual Meeting of Shareholders; Judge Orders Incumbent Board to Remain In Place Until Further Hearing; Final Outcome of Director Election Remains Uncertain
6. Dissident Stockholder Ted Karkus Found to Have Undisclosed Financial Arrangements With Dr. Richard A. Rosenbloom, COO Of Quigley Pharma, From 2008 to Date of Proxy: Rosenbloom Suspended Without Pay Pending Further Investigation
7. Karkus Nominees Caution Quigley Shareholders Not to be Fooled by the Companys Latest Announcement
8. The Quigley Corporation Announces Update on Strategic Alternatives and Commitment to Additional Review of Current Cost Structure
9. Judge Rejects Quigleys Claims - Karkus Director Candidates Prevail in Federal Court
10. Quigley Corporation Receives Support from Leading Independent Proxy Advisory Firms; RiskMetrics and Glass Lewis Reject Dissident Stockholder Ted Karkus, Citing Failure to Provide Detailed Business Plan
11. The Quigley Corporation Issues Open Letter to Stockholders; Urges Stockholders to Reject Dissident Ted Karkus Solicitation Efforts
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/30/2015)... ... June 30, 2015 , ... Micro ... company provides high quality record management services for patient records. Medical imaging includes ... required by physicians and clinics. , With the increase in the acceptance ...
(Date:6/30/2015)... Minn. (PRWEB) , ... June 30, 2015 , ... ... mobile-based nurse call and communications software, Notify™, for the senior care sector. As ... forefront of helping senior housing facilities to become more efficient and offer residents ...
(Date:6/30/2015)... ... June 30, 2015 , ... Harbor Village Detox is a drug ... Florida on June 12th. Holly Vasquez-Cortella was recently quoted as an expert in ... to reporting on trending addiction news and treatment innovations. The article highlights Florida governor ...
(Date:6/30/2015)... ... 30, 2015 , ... Nuretix Research, creators of the top ... (KO Zone), a state-of-the-art training facility owned by leading MMA, boxing, ... The partnership will provide KO Zone clients and athletes with Liporidex Fitness Formulas ...
(Date:6/30/2015)... ... , ... Due to today’s housing market, many people cannot afford to “down size” as they ... adjustments as to how to carry laundry or groceries from one level of their home ... or first floor of the home, and the bedrooms are located on another floor. ...
Breaking Medicine News(10 mins):Health News:Micro Com Systems Ltd Now Specializes in Medical Imaging 2Health News:Eldermark Leap-Frogs other Nurse Call and Communication Systems with Notify 2Health News:Eldermark Leap-Frogs other Nurse Call and Communication Systems with Notify 3Health News:Harbor Village Detox’s Clinical Director Is Quoted as an Addiction Expert by The Fix 2Health News:Harbor Village Detox’s Clinical Director Is Quoted as an Addiction Expert by The Fix 3Health News:Top Sports Nutrition Brand, Liporidex, Announces Partnership With Leading Boxing, CrossFit and MMA Gym, Knockout Zone of Miami 2Health News:Top Sports Nutrition Brand, Liporidex, Announces Partnership With Leading Boxing, CrossFit and MMA Gym, Knockout Zone of Miami 3Health News:Butler Mobility Products announce a Solution to Carry Items from One Floor to the Next with a Dumbwaiter 2
... 20 Progen Pharmaceuticals Limited (ASX: PGL; Nasdaq: ... its epigenetic technology successfully inhibits tumor growth.The results ... at the 100th Annual American Association for Cancer ... in ,switching on, important anti-cancer genes - a ...
... April 20 A new alliance between the ... leading manufacturer of unattended massage beds is focused ... a new and affordable service to customers.(Photo: ... Enterprises manufactures the HydroMassage, a massage system that ...
... the University of Southern California have identified a new ... surrounding blood vessels without the negative side effects typically ... 2.5-dimethyl-celecoxib (DMC) appears to have a strong anti-tumor effect ... supply necessary for tumor growth, according to data presented ...
... Fluorescent Channels to Enable Greater Data Ranges and Multiplexing ... Series Launched to Enable Imaging, Co-Registration and Data Fusion ... April 20 VisEn Medical Inc., a ... research through medicine, announced that users of its FMT ...
... added everolimus (Afinitor(R), Novartis) to the NCCN Guidelines for ... renal cell carcinoma whose disease has progressed after treatment ... of the March 30, 2009 FDA approval of everolimus ... that the therapy significantly extended progression-free survival in a ...
... Schwabe North America , has announced the ... Way sales teams. The integration marks an exciting ... Inc. by German-based Dr. Willmar Schwabe Pharmaceuticals, a leading ... years.The combined Specialty Retail Field Sales Team will service ...
Cached Medicine News:Health News:Progen Technology Switches on Cancer Fighting Genes and Inhibits Tumor Growth 2Health News:Progen Technology Switches on Cancer Fighting Genes and Inhibits Tumor Growth 3Health News:Progen Technology Switches on Cancer Fighting Genes and Inhibits Tumor Growth 4Health News:ETS Tan Now Exclusive Distributor of HydroMassage in U.S. 2Health News:USC researchers develop new drug to target tumor cells and blood vessels 2Health News:VisEn Medical Launches Expanded FMT 2500(TM) Imaging Platforms at AACR Meeting 2Health News:VisEn Medical Launches Expanded FMT 2500(TM) Imaging Platforms at AACR Meeting 3Health News:NCCN Updates Kidney Cancer Guidelines to Incorporate FDA Approval of Everolimus 2Health News:NCCN Updates Kidney Cancer Guidelines to Incorporate FDA Approval of Everolimus 3Health News:Schwabe North America Integrates Enzymatic Therapy and Nature's Way Sales Teams 2
(Date:6/30/2015)... Today, UBM China, a wholly owned subsidiary ... Tianyi Exhibition Co., Ltd. to jointly run the Health ... held concurrently with CWMEE 2016. This ... following MEDTEC China and DENTECH China, and fills its ... It,s also another concrete cooperative project in ...
(Date:6/30/2015)...  July 4 th is this weekend, a time ... and people behind it. To help honor our current nation,s ... USA Medical Card, a leading provider of free ... empower independence for our disabled military veterans, police, firemen, and ... their prescriptions. "Due to USA ...
(Date:6/30/2015)... 30, 2015  Marken, the leading clinical trial logistics ... industry, has been granted permission by the government to ... drug product in Korea.  This precedent-setting shipment has allowed ... to continue receiving their clinical trial drugs during the ... The emergency was caused by recent partial closures of ...
Breaking Medicine Technology:UBM Joins Chengdu Tianyi to Hold CWMEE 2016 2UBM Joins Chengdu Tianyi to Hold CWMEE 2016 3Hope For Heroes and USA Medical Card Make a Difference for Our Nation's Heroes 2Marken Delivers Direct To Patients During MERS Outbreak 2Marken Delivers Direct To Patients During MERS Outbreak 3
... , an industry-leading vendor of ambulatory healthcare software ... fastest-growing private companies in America. ... http://www.newscom.com/cgi-bin/prnh/20100817/INC5000LOGO ) The listing was published ... an exclusive compilation of the nation,s fastest-growing private ...
... 26 Wound Management Technologies, Inc. (OTC Bulletin Board: ... Wound Care Innovations, LLC has further expanded its rapidly ... the addition of Central Medical Systems to its already ... CMSI is the ideal type of distributor; they have ...
Cached Medicine Technology:Pulse Makes the 2010 Inc. 5000 List of the Fastest-Growing Private Companies in America 2Wound Management Technologies Expands Distribution Foot Print in Florida with the Addition of Central Medical Systems 2Wound Management Technologies Expands Distribution Foot Print in Florida with the Addition of Central Medical Systems 3
For the quantitative determination of Glycohemoglobin in blood....
The BioCheck Ferritin ELISA is intended for the quantitative determination of ferritin in human serum. This assay is to be used in the diagnosis of diseases affecting iron metabolism....
Rapid turn-around time, results in less than 4 hours...
... Bio-Rad isotopic anemia assays ... minimal ,pipetting steps for ... about the processes ,involved ... the benefit to your ...
Medicine Products: